Ionic Capital Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Ionic Capital Management’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-171,189	Closed	-$2.77K	–	297
2023 Q1	$2.77K	Buy	+171,189	New	+$4.3K	﹤0.01%	321
2022 Q1	–	Sell	-249,900	Closed	-$170K	–	479
2021 Q4	$170K	Hold	249,900	–	–	0.02%	305
2021 Q3	$155K	Hold	249,900	–	–	0.02%	284
2021 Q2	$160K	Hold	249,900	–	–	0.02%	316
2021 Q1	$130K	Hold	249,900	–	–	0.02%	273
2020 Q4	$222K	Buy	+249,900	New	+$170K	0.03%	185

Other funds holding REVBW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

Ionic Capital Management's REVBW Position: Q2 2023 in Review

Ionic Capital Management sold out of Revelation Biosciences Warrant (REVBW) in Q2 2023, closing a stake of 171,189 shares — an estimated $2.77K sold.

Ionic Capital Management first reported a position in REVBW in Q4 2020 and held it in 6 quarters. The position peaked at $222K in Q4 2020. 12 funds tracked by Wall St. Rank hold REVBW as of Q2 2023.

Ionic Capital Management reported no remaining Revelation Biosciences Warrant position as of Q2 2023 after selling out during the quarter.
Ionic Capital Management sold 171,189 Revelation Biosciences Warrant shares in Q2 2023, an estimated $2.77K.
Ionic Capital Management first reported a position in Revelation Biosciences Warrant in Q4 2020 and held it in 6 quarters.
Ionic Capital Management's Revelation Biosciences Warrant position peaked at $222K in Q4 2020.
12 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2023.

Based on Ionic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.